Article
Driver mutation impact in Chinese hepatocellular carcinoma.
PloS one - 1 Jan 2026
Wu Ruiheng, Xing Houmin, Townsend Jeffrey P
Abstract excerpt
Hepatocellular carcinoma (HCC) remains a leading cause of cancer mortality in China. The Chinese Liver Cancer Atlas (CLCA) recently reported whole-genome sequencing of 494 HCC tumors, nominating 23 coding and 31 non-coding driver candidates based on combined P values across multiple algorithms. However, the statistical significance of recurrence alone does not distinguish functionally impactful drivers from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
